Targeting ion channels for the treatment of gastrointestinal motility disorders
about
Ano1, a Ca2+-activated Cl- channel, coordinates contractility in mouse intestine by Ca2+ transient coordination between interstitial cells of CajalLoss-of-Function of the Voltage-Gated Sodium Channel NaV1.5 (Channelopathies) in Patients With Irritable Bowel SyndromeIon channelopathies in functional GI disorders.Recent progress in gastric arrhythmia: pathophysiology, clinical significance and future horizonsRanolazine inhibits voltage-gated mechanosensitive sodium channels in human colon circular smooth muscle cells.Targeting Ion Channels: An Important Therapeutic Implication in Gastrointestinal Dysmotility in Patients With Spinal Cord InjuryExpression and function of the Scn5a-encoded voltage-gated sodium channel NaV 1.5 in the rat jejunum.Calcium Signaling in Interstitial Cells: Focus on Telocytes.Computational modeling of anoctamin 1 calcium-activated chloride channels as pacemaker channels in interstitial cells of Cajal.Colonic smooth muscle cells and colonic motility patterns as a target for irritable bowel syndrome therapy: mechanisms of action of otilonium bromide.Basal cGMP regulates the resting pacemaker potential frequency of cultured mouse colonic interstitial cells of Cajal.Irritable bowel syndrome (IBS) patients have SCN5A channelopathies that lead to decreased NaV1.5 current and mechanosensitivity.Effect of mosapride on Kv4.3 potassium channels expressed in CHO cells.TREK-1 Channel Expression in Smooth Muscle as a Target for Regulating Murine Intestinal Contractility: Therapeutic Implications for Motility Disorders.Comparative pharmacokinetics of (S)-MP3950, a novel 5-HT4 receptor agonist, in normal and atropine-induced gastrointestinal motility disorders rats.Saturated long-chain fatty acid-producing bacteria contribute to enhanced colonic motility in rats.Relaxant effects of A. Juss var. Valeton flower extract on isolated rat ileum contractions and the mechanisms of action
P2860
Q28654692-6B9AFD75-15E5-4FD0-9E7A-4C27135C5F72Q29544671-9BBC661D-89BA-458C-810C-EBC3F4A46CB3Q34537076-F9FCE4EA-05DA-4A76-87DC-1AAFE7EC6874Q35178302-3DE43E4A-BB78-4C15-8547-ECAFF69B6EE6Q36066445-1501AF39-F2E7-4908-B52D-B0F32F7577F3Q36211724-B455D9D1-444F-4683-8928-8FD3981405C3Q36395633-FCDA7004-DC7F-4783-9922-7F2DD826B531Q37690948-11A59AF2-E277-4819-8C1C-D448A104BE09Q37707558-F764BCA0-823D-40D2-91B8-7E3C7E9BB46FQ38233357-FA76D40C-699C-45D6-BB14-8BE9EB5BFB74Q42456487-A3F5EC01-49F2-4DD3-B291-A704761E1885Q49789569-9925E18B-2918-48F8-A86E-18B48A549272Q50884850-6A250A1A-82EB-4D96-9363-DC9EFD1CF57AQ52689982-858DD90B-755E-4823-B31E-4D1DF991B5E1Q53121069-BA115442-5E2C-487E-AB7B-92C9F852A4FEQ55439068-94F1EA3E-C8AF-472F-AF8E-896C55D2FD89Q57301408-1AC332B3-BF7A-4281-A8CE-444ED3C0A43E
P2860
Targeting ion channels for the treatment of gastrointestinal motility disorders
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Targeting ion channels for the treatment of gastrointestinal motility disorders
@en
Targeting ion channels for the treatment of gastrointestinal motility disorders.
@nl
type
label
Targeting ion channels for the treatment of gastrointestinal motility disorders
@en
Targeting ion channels for the treatment of gastrointestinal motility disorders.
@nl
prefLabel
Targeting ion channels for the treatment of gastrointestinal motility disorders
@en
Targeting ion channels for the treatment of gastrointestinal motility disorders.
@nl
P2860
P356
P1476
Targeting ion channels for the treatment of gastrointestinal motility disorders
@en
P2093
Arthur Beyder
Gianrico Farrugia
P2860
P356
10.1177/1756283X11415892
P577
2012-01-01T00:00:00Z